Price (delayed)
$1.53
Market cap
$34.4M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.18
Enterprise value
$93.17M
Highlights
Celularity's EPS has surged by 88% YoY and by 78% QoQ
The company's net income has surged by 81% YoY and by 69% QoQ
CELU's equity is down by 43% year-on-year and by 38% since the previous quarter
The quick ratio has declined by 29% since the previous quarter
Key stats
What are the main financial stats of CELU
MarketValuationsEarnings
Shares outstanding
22.48M
Market cap
$34.4M
Enterprise value
$93.17M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.95
Price to sales (P/S)
0.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.93
Revenue
$48.2M
Gross profit
$27.38M
Operating income
-$15.76M
Net income
-$35.05M
EBIT
-$29.93M
EBITDA
-$21.41M
Free cash flow
-$13.02M
Per shareBalance sheetLiquidity
EPS
-$1.18
EPS diluted
-$1.18
Free cash flow per share
-$0.59
Book value per share
$0.79
Revenue per share
$2.19
TBVPS
$5.09
Total assets
$128.84M
Total liabilities
$111.56M
Debt
$69.06M
Equity
$17.28M
Working capital
-$61.67M
Debt to equity
4
Current ratio
0.19
Quick ratio
0.25
Net debt/EBITDA
-2.74
MarginsEfficiencyDividend
EBITDA margin
-44.4%
Gross margin
56.8%
Net margin
-72.7%
Operating margin
-32.7%
Return on assets
-25.4%
Return on equity
-119.5%
Return on invested capital
-27.9%
Return on capital employed
-56.8%
Return on sales
-62.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CELU stock price
How has the Celularity stock price performed over time
Intraday
-6.13%
1 week
-18.62%
1 month
30.77%
1 year
-70.97%
YTD
-26.44%
QTD
-11.56%
Financial performance
How have Celularity's revenue and profit performed over time
Revenue
$48.2M
Gross profit
$27.38M
Operating income
-$15.76M
Net income
-$35.05M
Gross margin
56.8%
Net margin
-72.7%
CELU financials
Celularity's operating margin has surged by 99% YoY and by 87% QoQ
Celularity's operating income has soared by 95% YoY and by 85% from the previous quarter
CELU's net margin has surged by 94% year-on-year and by 72% since the previous quarter
The company's net income has surged by 81% YoY and by 69% QoQ
Growth
What is Celularity's growth rate over time
CELU growth chart
Valuation
What is Celularity stock price valuation
P/E
N/A
P/B
1.95
P/S
0.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.93
Price to earnings (P/E)
Celularity's EPS has surged by 88% YoY and by 78% QoQ
Price to book (P/B)
CELU's equity is down by 43% year-on-year and by 38% since the previous quarter
The P/B is 25% less than the last 4 quarters average of 2.6
Price to sales (P/S)
CELU's P/S is 95% below its 5-year quarterly average of 13.2 and 67% below its last 4 quarters average of 2.1
CELU's revenue is up by 13% since the previous quarter
Efficiency
How efficient is Celularity business performance
Celularity's return on sales has surged by 95% YoY and by 76% QoQ
CELU's return on invested capital has surged by 81% year-on-year and by 72% since the previous quarter
CELU's ROA has soared by 67% since the previous quarter and by 59% year-on-year
The return on equity has surged by 66% since the previous quarter and by 17% year-on-year
Dividends
What is CELU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CELU.
Financial health
How did Celularity financials performed over time
Assets vs liabilities
CELU's total assets is 15% greater than its total liabilities
The quick ratio has declined by 29% since the previous quarter
Celularity's current ratio has decreased by 27% QoQ
Debt vs equity
The debt to equity has soared by 98% YoY and by 65% from the previous quarter
CELU's equity is down by 43% year-on-year and by 38% since the previous quarter
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from 
and Sharadar.